Biotechnology M&A » By The Online Investor Staff, updated Tue., Apr. 20, 2:39 AM
Recent mergers and acquisitions in the Biotechnology M&A category.
| This Slide: #8 of 83 |
Slide #8. AMRI — Cedarburg Pharmaceuticals, Inc.
Acquirer:
AMRI (AMRI)
Acquiree:
Cedarburg Pharmaceuticals, Inc.
Details:
AMRI (NASDAQ: AMRI) today announced that it has completed the previously announced acquisition of Cedarburg Pharmaceuticals, Inc.
Albany Molecular Research is a contract research and manufacturing organization providing customers integrated drug discovery, development, and manufacturing services. Co. has three segments: Discovery and Development Services, which include provides a range of chemical development technologies for route development; Active Pharmaceutical Ingredients, which provides chemical synthesis and manufacturing services for its customers; drug product, which provides facilities to deliver integrated pharmaceutical drug development programs and services; and Fine Chemicals, which provides lab to commercial scale synthesis of reagents and diverse compounds to the pharmaceutical, among others.
Open the AMRI Page at The Online Investor »
|
|||||||||
Open the AMRI Page at The Online Investor (in a new window) »
|
|
Avg. Broker Rec.
|
Hold (2.00 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |
